Family Resilience and Coping in Disasters, Pandemics, and Large-Scale Crises: A Systematic Review.

Disaster Med Public Health PrepOct 26, 2026 (epub)

Mufarika Mufarika, Arief Hargono, Abdul Hadi Furqoni

✦ AI-curated · Sources linked

In 30 seconds

This systematic review synthesized peer-reviewed research on family resilience and coping during disasters, pandemics, and sustained adversity. Following PRISMA 2020 principles, the authors included 42 studies in a qualitative synthesis using narrative and thematic methods. Family resilience was commonly characterized as a dynamic, family-level process involving shared meaning-making, organizational flexibility, and effective communication. Parenting practices repeatedly appeared to link family resilience with child adjustment. Resilience-oriented family interventions were reported to have overall beneficial effects across disaster, pandemic, and serious illness contexts, with no evidence of harm.

Key findings

  • The qualitative synthesis included 42 studies across disaster, pandemic, and sustained-adversity contexts.
  • Family resilience was most often described through shared meaning-making, organizational flexibility, and effective communication.
  • Parenting practices repeatedly emerged as a pathway linking family resilience with child adjustment.
  • Resilience-oriented family interventions showed overall beneficial effects, with no evidence of harm.

Why it matters

The review frames adaptation to crises as involving family-level processes, not only individual coping. Its findings highlight communication, flexible organization, shared meaning, and supportive parenting as recurring features associated with resilience and child adjustment. This perspective may help inform psychosocial support and preparedness efforts that account for family functioning during prolonged adversity.

What to keep in mind

The synthesis was qualitative and narrative, so the abstract does not provide pooled effect estimates or quantify intervention benefits.

Source

Published in Disaster Med Public Health Prep. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.